Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Long-Term Debt Repayments (2018 - 2019)

Organogenesis Holdings (ORGO) has 2 years of Long-Term Debt Repayments data on record, last reported at $17.6 million in Q3 2019.

  • For Q3 2019, Long-Term Debt Repayments changed N/A year-over-year to $17.6 million; the TTM value through Dec 2021 reached $35.2 million, down 33.33%, while the annual FY2021 figure was -$60.0 million, 700.0% down from the prior year.
  • Long-Term Debt Repayments reached $17.6 million in Q3 2019 per ORGO's latest filing, roughly flat from $17.6 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $17.6 million in Q1 2019 and bottomed at $10000.0 in Q1 2018.